See also this year's filing and all EDGAR filings for this company.
PDF Report 0001593184_2023_Bioregenx_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001593184')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001593184')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001593184, Bioregenx INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 676 |
| 1 | AssetsNonCurrent | 0 |
| 2 | PropertyPlantAndEquipment | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | LeaseAssets | 0 |
| 5 | remainder_Assets | 58,473 |
| 6 | LiabilitiesCurrent | 64,880 |
| 7 | LiabilitiesNonCurrent | 195,811 |
| 8 | LeaseLiability | 0 |
| 9 | remainder_Liabilities | 0 |
| 10 | CostOfGoodsAndServicesSold | 0 |
| 11 | GeneralAndAdministrativeExpense | 0 |
| 12 | SellingExpense | 0 |
| 13 | ResearchAndDevelopmentExpense | 0 |
| 14 | remainder_Expenses | 120,467 |
| 15 | remainder_Revenues | 42,159 |
| 16 | remainder_NetIncome | 0 |
| 17 | remainder_ComprehensiveNetIncome | -39,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 59,149 |
| 1 | Liabilities | 260,691 |
| 2 | Expenses | 120,467 |
| 3 | Revenues | 42,159 |
| 4 | StockholdersEquity | -201,542 |
| 5 | NetIncome | -78,308 |
| 6 | ComprehensiveNetIncome | -117,308 |
| 7 | BaseVar | 264,766 |
| 8 | EconomicCapitalRatio | -3.76 |
Edgar->Model Mapping
Feature Distribution
